NCCR Unveils Six New Public Service TV Announcements

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 3
Volume 4
Issue 3

WASHINGTON--The National Coalition for Cancer Research (NCCR), a Washington coalition of more than 20 cancer-related organizations founded in 1986, unveiled its new series of six 30-second television public service announcements at a

WASHINGTON--The National Coalition for Cancer Research (NCCR),a Washington coalition of more than 20 cancer-related organizationsfounded in 1986, unveiled its new series of six 30-second televisionpublic service announcements at a Capitol Hill ceremony. The campaignalso includes airport dioramas that repeat the TV messages.

Speaking about the budget process in which the 104th Congressis currently engaged, Rep. John Porter (R-Ill) reassured the Coalition:"Everybody agrees that downsizing is necessary, but cancerresearch is one place where we definitely do not want to cut."

Rep. Porter, chairman of the House Appropriations Subcommitteeon Labor, Health and Human Services, and Education and RelatedAgencies, pointed out in his talk that biomedical research isimportant not only for its role in finding ways to prevent andcure cancer, but also for the overall economy, since such researchprovides the country with "thousands of high-tech jobs."

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Related Content